Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response.
about
High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma.Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma.Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy.
P2860
Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Early response to high-dose me ...... eving early complete response.
@ast
Early response to high-dose me ...... eving early complete response.
@en
type
label
Early response to high-dose me ...... eving early complete response.
@ast
Early response to high-dose me ...... eving early complete response.
@en
prefLabel
Early response to high-dose me ...... eving early complete response.
@ast
Early response to high-dose me ...... eving early complete response.
@en
P2093
P2860
P50
P1433
P1476
Early response to high-dose me ...... eving early complete response.
@en
P2093
Doh Yu Hwang
Ji Eun Jang
Jong Hee Chang
June-Won Cheong
Shin Young Hyun
Soo-Jeong Kim
Yoo Hong Min
Yundeok Kim
P2860
P304
P356
10.1007/S00277-013-1853-7
P577
2013-08-01T00:00:00Z